Dana Sachs
Overview
Explore the profile of Dana Sachs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chien A, Qi J, Cheng N, Do T, Mesfin M, Egbers R, et al.
J Am Acad Dermatol
. 2016 Jan;
74(5):924-30.
PMID: 26803346
Background: Perioral wrinkling is commonly reported among older adults, but its objective evaluation and causes remain poorly understood. Objective: We sought to develop a photonumeric scale for perioral wrinkling and...
2.
Helfrich Y, Maier L, Cui Y, Fisher G, Chubb H, Fligiel S, et al.
JAMA Dermatol
. 2015 Mar;
151(8):825-36.
PMID: 25798811
Importance: Facial erythema and telangiectasia are commonly associated with the erythematotelangiectatic subtype of rosacea (ETR). It is important for clinicians to recognize that these findings can also be associated with...
3.
Do T, Zarkhin S, S Orringer J, Nemeth S, Hamilton T, Sachs D, et al.
J Am Acad Dermatol
. 2008 Feb;
58(4):603-8.
PMID: 18249468
Background: Inflammatory acne lesions are believed to derive from comedones; however, their evolution has not been rigorously studied. Objective: To examine the evolution of facial acne lesions using serial digital...
4.
Changchien L, Dusza S, Agero A, Korzenko A, Braun R, Sachs D, et al.
Arch Dermatol
. 2007 Aug;
143(8):1007-14.
PMID: 17709659
Objectives: To describe the dermoscopic features of congenital melanocytic nevi (CMN) and assess whether predominant dermoscopic patterns present in CMN are related to an individual's age (<12 years vs >or=12...
5.
Gerecitano J, Goy A, Wright J, MacGregor-Cortelli B, Neylon E, Gonen M, et al.
Br J Haematol
. 2006 Aug;
134(4):391-8.
PMID: 16882131
Bortezomib is the first proteasome inhibitor to be approved for use in haematological malignancies. Although a rash has been described as a common adverse event associated with the drug, it...
6.
Leonard G, Sachs D, Kemeny N
Dig Dis Sci
. 2004 Dec;
49(10):1652-3.
PMID: 15573921
No abstract available.
7.
Oliveria S, Geller A, Dusza S, Marghoob A, Sachs D, Weinstock M, et al.
Arch Dermatol
. 2004 May;
140(5):545-51.
PMID: 15148098
Objectives: To (1). describe nevus patterns using digital photography and dermoscopy; (2). evaluate the relationship between host and environmental factors and prevalence of nevi in schoolchildren; and (3). demonstrate the...
8.
Oliveria S, Sachs D, Belasco K, Halpern A
J Am Acad Dermatol
. 2003 Oct;
49(5):955-9.
PMID: 14576692
The identification and diagnosis of early melanoma will reduce unnecessary operations and may be important in reducing mortality from melanoma and impacting cost savings to the health system. New technologies...
9.
Sanders S, Busam K, Tahan S, Johnson R, Sachs D
J Am Acad Dermatol
. 2002 Mar;
46(4):611-6.
PMID: 11907520
It has previously been reported that interferon alfa injection sites may develop pyoderma gangrenosum, interface dermatitis, vasculitis, or, more commonly, ulcers characterized by intravascular thrombi and a mixed inflammatory cell...